HEALTH● LOWAug 13 · Aug 13, 2026, 4:48 AM
Biocardia outlines Japan CardiAMP Shonin submission next quarter with approval expected about 12 months later
Seeking Alpha Tech
Biocardia plans to submit its Japan CardiAMP Shonin next quarter, with approval anticipated approximately 12 months later. This outlines a key regulatory milestone for the company's medical technology.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH52m ago"The Pope has lung cancer!": reactions in the world's main mediaClarínHEALTH56m agoKarnataka Health Minister urges public to use alternatives as 108 ambulance workers threaten strike from October 14 nightThe HinduHEALTH1h ago"Global health is a team sport": World Health Summit in BerlinEuroNews [en]HEALTH1h agoSPECIAL REPORT: Insecurity exposes Zamfara communities to recurring cholera outbreaksPremium Times